Seelos Therapeutics (SEEL) Short Interest Ratio & Short Volume → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free SEEL Stock Alerts $0.29 -0.01 (-3.49%) (As of 09:40 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Seelos Therapeutics Short Interest DataCurrent Short Volume726,800 sharesPrevious Short Volume815,000 sharesChange Vs. Previous Month-10.82%Dollar Volume Sold Short$429,538.80Short Interest Ratio / Days to Cover1.6Last Record DateMarch 31, 2024Outstanding Shares13,680,000 sharesFloat Size12,490,000 sharesShort Percent of Float5.82%Today's Trading Volume19,358 sharesAverage Trading Volume424,981 sharesToday's Volume Vs. Average5% Short Selling Seelos Therapeutics ? Sign up to receive the latest short interest report for Seelos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSEEL Short Interest Over TimeSEEL Days to Cover Over TimeSEEL Percentage of Float Shorted Over Time Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Seelos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024726,800 shares $429,538.80 -10.8%5.8%1.6 $0.59 3/15/2024815,000 shares $812,962.50 +178.2%6.5%1.9 $1.00 2/29/2024293,000 shares $377,970.00 -5.6%2.4%0.6 $1.29 2/15/2024310,500 shares $258,056.55 -24.1%2.6%0.4 $0.83 1/31/2024409,100 shares $417,282.00 -70.1%3.4%0.6 $1.02 1/15/20241,370,000 shares $1.93 million +61.8%14.4%2.1 $1.41 Get the Latest News and Ratings for SEEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seelos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023846,900 shares $1.18 million -1.4%8.9%1.4 $1.39 12/15/2023859,300 shares $1.34 million +6.2%9.2%1.5 $1.56 11/30/2023808,800 shares $1.02 million -91.6%11.2%1.4 $1.26 11/15/20239,650,000 shares $34.88 million +16.0%N/A1.6 $3.62 10/31/20238,320,000 shares $1.55 million -0.8%N/A1.6 $0.19 10/15/20238,390,000 shares $1.54 million -18.0%N/A1.8 $0.18 9/30/202310,230,000 shares $1.88 million +66.3%N/A2.5 $0.18 9/15/20236,150,000 shares $5.67 million +2.0%N/A2 $0.92 8/31/20236,030,000 shares $6.57 million +10.4%N/A6.6 $1.09 8/15/20235,460,000 shares $6.39 million -2.0%N/A6.3 $1.17 7/31/20235,570,000 shares $8.52 million +5.3%N/A7.5 $1.53 7/15/20235,290,000 shares $6.98 million -4.3%N/A7.8 $1.32 6/30/20235,530,000 shares $6.61 million -3.0%N/A10 $1.20 6/15/20235,700,000 shares $5.99 million +4.0%N/A11.1 $1.05 5/31/20235,480,000 shares $5.10 million -5.7%N/A11.7 $0.93 5/15/20235,810,000 shares $5.28 million -11.0%N/A11.2 $0.91 4/30/20236,530,000 shares $4.51 million +3.8%N/A12.6 $0.69 4/15/20236,290,000 shares $4.91 million -6.1%N/A11.6 $0.78 3/31/20236,700,000 shares $4.63 million -1.0%N/A12 $0.69 3/15/20236,770,000 shares $4.23 million +7.5%N/A11.1 $0.63 2/28/20236,300,000 shares $4.98 million +5.7%N/A9.2 $0.79 2/15/20235,960,000 shares $4.41 million +4.4%N/A9 $0.74 1/31/20235,710,000 shares $4.64 million -0.4%N/A9.1 $0.81 1/15/20235,730,000 shares $5.21 million No ChangeN/A8.8 $0.91 12/30/20225,730,000 shares $3.89 million -3.2%N/A9 $0.68 12/15/20225,920,000 shares $6.45 million +1.7%N/A9.3 $1.09 11/30/20225,820,000 shares $4.76 million +4.7%N/A8.8 $0.82 11/15/20225,560,000 shares $5.00 million -3.1%N/A8 $0.90 10/31/20225,740,000 shares $4.99 million -10.0%N/A6 $0.87 10/15/20226,380,000 shares $5.79 million +0.2%N/A6.4 $0.91 9/30/20226,370,000 shares $6.56 million +1.8%N/A6.3 $1.03 9/15/20226,260,000 shares $8.01 million +11.0%N/A4.7 $1.28 8/31/20225,640,000 shares $6.37 million +5.8%N/A4.3 $1.13 8/15/20225,330,000 shares $5.20 million -12.2%N/A3.9 $0.98A new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. SEEL Short Interest - Frequently Asked Questions What is Seelos Therapeutics' current short interest? Short interest is the volume of Seelos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 726,800 shares of SEEL short. 5.82% of Seelos Therapeutics' shares are currently sold short. Learn More on Seelos Therapeutics' current short interest. What is a good short interest ratio for Seelos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SEEL shares currently have a short interest ratio of 2.0. Learn More on Seelos Therapeutics's short interest ratio. What is a good short interest percentage for Seelos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.82% of Seelos Therapeutics' floating shares are currently sold short. Is Seelos Therapeutics' short interest increasing or decreasing? Seelos Therapeutics saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 726,800 shares, a decrease of 10.8% from the previous total of 815,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Seelos Therapeutics' float size? Seelos Therapeutics currently has issued a total of 13,680,000 shares. Some of Seelos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Seelos Therapeutics currently has a public float of 12,490,000 shares. How does Seelos Therapeutics' short interest compare to its competitors? 5.82% of Seelos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Seelos Therapeutics: Tharimmune, Inc. (0.65%), Genprex, Inc. (3.78%), Cingulate Inc. (1.21%), Lipella Pharmaceuticals Inc. (1.24%), Longeveron Inc. (3.10%), Processa Pharmaceuticals, Inc. (1.56%), ZyVersa Therapeutics, Inc. (8.09%), Exicure, Inc. (2.40%), Petros Pharmaceuticals, Inc. (3.57%), NexImmune, Inc. (2.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Seelos Therapeutics stock? Short selling SEEL is an investing strategy that aims to generate trading profit from Seelos Therapeutics as its price is falling. SEEL shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Seelos Therapeutics? A short squeeze for Seelos Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SEEL, which in turn drives the price of the stock up even further. How often is Seelos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SEEL, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: THAR Short Interest GNPX Short Interest CING Short Interest LIPO Short Interest LGVN Short Interest PCSA Short Interest ZVSA Short Interest XCUR Short Interest PTPI Short Interest NEXI Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SEEL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport Society